1995•Biochimica et Biophysica Acta (BBA) - Lipids and Lipid MetabolismRequires access

The mechanism of lack of hypocholesterolemic effects of pravastatin sodium, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, in rats

Tomoyuki Fujioka, Futoshi Nara, Yoshio Tsujita, Junichiro Fukushige, Masaharu Fukami, Masao Kuroda

Open publisher page 94 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 94 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Pravastatin, Endocrinology, Internal medicine, Cholesterol, Reductase, HMG-CoA reductase, Hydroxymethylglutaryl-CoA reductase, Very low-density lipoprotein

Back to paper search Browse research topics Original source

The mechanism of lack of hypocholesterolemic effects of pravastatin sodium, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, in rats — Research Paper | ScholarLens